DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Share Price

Certificat

DE000ME7XE02

Market Closed - Börse Stuttgart 11:38:01 31/05/2024 pm IST
165.6 EUR -0.07% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month-1.06%
1 month-1.06%
Date Price Change
31/24/31 165.6 -0.07%
30/24/30 165.8 -0.19%
29/24/29 166.1 +2.85%
28/24/28 161.5 -0.04%
27/24/27 161.6 -2.37%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 11:38 pm IST

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME7XE0
ISINDE000ME7XE02
Date issued 30/01/2024
Maturity 21/06/2024 (21 Days)
Parity 1 : 1
Emission price 165.4
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 168
Lowest since issue 161.2
Spread 0.23
Spread %0.14%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232 USD
Average target price
278.7 USD
Spread / Average Target
+20.14%
Consensus